See our TRT overview for how the two programs interact
GERD affects 20% of adults in developed countries, and current therapies leave significant gaps
Practical take For clinicians, this reinforces a more nuanced approach: Match the drug to the patient profile Look beyond average weight loss alone Consider tolerability, adherence, comorbidities, access, and long-term strategy The obesity pipeline is getting deeperand that is good news for patients
Using them together isn't necessarily bad, but it can overwhelm sensitive skin
Ligands of nuclear receptors, such as 1,25-dihydroxyvitamin D3, cross the plasma membrane and directly activate the cytosolic nuclear vitamin D receptor [81, 144, 145]